Re-evaluating AKT regulation: role of TOR complex 2 in tissue growth

Ville Hietakangas1, Stephen M Cohen

  • 1European Molecular Biology Laboratory Meyerhofstrasse 1, D-69117 Heidelberg, Germany.

Genes & Development
|March 21, 2007
PubMed

Insights

Target of rapamycin complex 2 (TORC2) regulates Phosphatidylinositol-3-kinase (PI3K)/AKT signaling. Loss of TORC2 activity in Drosophila inhibits hyperplasia by modulating AKT signaling at high pathway activity levels.

Area of Science:

  • Cellular signaling pathways
  • Molecular biology
  • Cancer research

Background:

  • Phosphatidylinositol-3-kinase (PI3K)/AKT signaling is crucial for cell growth, metabolism, and is frequently dysregulated in cancer.
  • AKT activity is regulated by phosphorylation at conserved sites by PDK1 and target of rapamycin (TOR) complex 2 (TORC2).

Purpose of the Study:

  • To investigate the role of TORC2-mediated AKT phosphorylation in Drosophila.
  • To understand how TORC2 modulates AKT signaling, particularly in the context of elevated pathway activity.

Main Methods:

  • Analysis of Drosophila mutants lacking critical TORC2 components (rictor, sin1).
  • Assessment of AKT hydrophobic motif (HM) phosphorylation and AKT activity.
  • Evaluation of hyperplasia in response to altered PI3K/AKT pathway activity.

Main Results:

  • Mutants lacking rictor or sin1 showed reduced AKT HM phosphorylation and activity, with minimal impact on normal growth.
  • A mutant AKT lacking the HM phosphorylation site exhibited comparable activity to wild-type.
  • Loss of TORC2 activity significantly inhibited hyperplasia caused by elevated PI3K/AKT signaling, such as in PTEN mutants.

Conclusions:

  • TORC2 plays a critical role in regulating AKT activity, especially at higher signaling levels.
  • TORC2 functions as a rheostat, expanding the dynamic range of AKT signaling.
  • These findings highlight TORC2's importance in controlling pathway flux and its implications in cancer biology.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...